The expression of Claudin-4 (CLDN4) is positively correlated with PAK4 in breast cancer and PAK4 induces CCAAT/enhancer binding protein β (CEBPB) activation, resulting in upregulation of CLDN4. This evidence concerns the gene CLDN4 and breast carcinoma.